EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
AIM ImmunoTech Inc. (AIM) had EBITDA Margin of -11280.59% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.17M |
|
$-17.32M |
|
$0.03M |
|
$0.14M |
|
$19.94M |
|
$-19.77M |
|
$2.45M |
|
$-17.32M |
|
$-17.23M |
|
$-17.32M |
|
$-17.32M |
|
$-17.32M |
|
$-17.23M |
|
$-19.77M |
|
$-19.18M |
|
0.56M |
|
0.56M |
|
$-31.00 |
|
$-31.00 |
|
| Balance Sheet Financials | |
$4.18M |
|
$0.11M |
|
$4.43M |
|
$8.61M |
|
$9.54M |
|
-- |
|
$0.40M |
|
$9.93M |
|
$-1.32M |
|
$-3.92M |
|
$-1.32M |
|
0.66M |
|
| Cash Flow Statement Financials | |
$-14.89M |
|
$4.71M |
|
$6.44M |
|
$5.44M |
|
$1.70M |
|
$-3.74M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.44 |
|
-- |
|
-- |
|
-- |
|
-1.75 |
|
81.76% |
|
-11630.59% |
|
-11630.59% |
|
|
EBITDA Margin |
-11280.59% |
-10188.23% |
|
-10188.23% |
|
$-14.91M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
1310.14% |
|
442.29% |
|
-201.21% |
|
1310.14% |
|
$-2.02 |
|
$-26.61 |
|
$-26.58 |
|